Reforming the 340B Program Will Lower the Price of Prescription Drugs

Abuse of an obscure drug discount program (340B) is leading to higher overall health care costs and greater market distortions. Congress should reform the 340B program to eliminate these cost drivers and disincentives.October 10, 2017 at 11:02AM

via Forbes Real Time